Popular Articles

Pelleve Receives FDA Clearance For The Treatment Of Mild To Moderate Facial Wrinkles
Ellman International, Inc. announced that the Food and Drug Administration (FDA) has granted clearance to Pelleve(TM), a skin tightening system for the non-ablative treatment of mild to moderate facial wrinkles and rhytids for skin phototypes I-IV. The clearance was granted based on clinical data demonstrating that a single treatment with the high frequency radiowave device can safely and effectively tighten and improve the appearance of skin on the face through six months.
generic viagra online
Cytokinetics Announces The Initiation Of A First-Time-in-Humans, Phase I Clinical Trial Of CK-2017357
Cytokinetics, Incorporated (NASDAQ: CYTK) announced that the company has initiated a first-time-in-humans, Phase I clinical trial of CK-2017357 in healthy male volunteers. CK-2017357 is a fast skeletal muscle troponin activator and is the lead drug candidate that has emerged from the company"s skeletal sarcomere activator program. CK-2017357 selectively activates the troponin complex and increases its sensitivity to calcium, subsequently leading to an increase in skeletal muscle force. This mechanism of action has demonstrated encouraging pharmacological activity in preclinical models that may relate to the potential treatment of diseases associated with aging, muscle wasting, and neuromuscular dysfunction.
News of the day
Swine Flu (H1N1) Infectivity To Increase Markedly And Lethality To Remain Low According To Latest Replikin Peptide Genomic Data
Amid all the speculation over what course the Swine Flu epidemic will take, Boston-based biotech firm Replikins Ltd. last week analyzed the most recent peptide genomic sequence data available and determined that the infectivity of the H1N1 virus will increase markedly, while its lethality will remain relatively low for the immediate future.
Medical Devices

Using The Internet To Help Young Smokers Quit

Many young smokers want to quit but don"t know what methods work. The University of Illinois at Chicago is leading a $2.9 million National Cancer Institute project to increase demand for evidence-based, Internet-based smoking cessation treatment among young adults. "Even though many young adults think about quitting and actually want to stop smoking, they tend not to use what we know works - evidence-based approaches to quitting," said psychology professor Robin Mermelstein, director of UIC"s Institute for Health Research and Policy and principal investigator of the five-year study. Young adults between the ages of 18 and 24 have the highest rates of smoking compared to any other age group, but they have among the lowest rates of quitting, according to Mermelstein. A multidisciplinary team of investigators from UIC, the University of Iowa and the American Legacy Foundation will work with GDS&M Idea City advertising agency to develop interactive, Internet-based ads and evaluate what messages motivate young smokers to use the evidence-based stop smoking program www.BecomeAnEx.org. "Our prior research has shown that if you want to reach and engage young adults, then you need to go where they are, and the Internet is it," said Mermelstein. "Our approach is to develop messages that might have enduring value and deliver these messages across the Internet to drive the demand of young adults to seek evidence-based treatments. Ultimately, we want to help young smokers to quit smoking now before they continue to accrue the health risks associated with smoking." Research has shown that young adults have misconceptions about treatment and a lack of awareness about treatment availability and accessibility. "They often express skepticism about treatments, or think they are better off using alternative approaches, and tend to dismiss what we know works," said Mermelstein. "We need to demystify those beliefs about treatment; that treatment is not bad, that it"s often the surest way to quit." The nationwide study will enroll more than 3,000 young smokers via the Internet, recruiting through sites like Craigslist. The four-part study will develop Internet-based ads, evaluate if the ads are reaching young adults and driving them to Internet-based cessation programs, determine if the approaches are effective, and find out if those who used the Internet-based program were successful in stopping smoking. Sherri McGinnis Gonzç¡lez University of Illinois at Chicago


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):